The clinical and immunologic impact of using interferon and ribavirin in the immunosuppressed host
β Scribed by Marius Braun; John M. Vierling
- Book ID
- 111723503
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 108 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1527-6465
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The aim of the present study was to clarify the significance of viral factors for pretreatment prediction of sustained virological response to pegylatedβinterferon (PEGβIFN) plus ribavirin (RBV) therapy for chronic hepatitis C using data mining analysis. Substitutions in the IFN sensiti
In their paper in the November issue of HEPATOLOGY, Younossi et al. 1 may have overestimated the cost effectiveness of interferon-ribavirin treatment. This mainly stems from their failure to take into account the fact that patients who achieve sustained response are not homogenous with respect to th